Leverage The Lab Learn how Abbott's strategic transformation plan provided laboratories insights and health system performance improvements
The reported COL3A1 mutations are either exon-skipping mutations or missense mutations that disrupt the collagen triple helix (4)
Cero tiempo de inactividad: los clientes se van con una piel radiante y regresan a sus actividades normales de inmediato

Key Insights Fatigue is a common but usually temporary side effect during the initial weeks or dose changes in GLP-1 therapy, caused largely by rapid calorie deficit, dehydration, and metabolic adjustments. Maintaining steady energy requires prioritising nutrient-dense meals rich in protein and complex carbohydrates, staying well hydrated, and managing electrolyte balance, which helps mitigate tiredness and supports overall metabolism. Gentle physical activity and good sleep hygiene are critical lifestyle adjustments that improve circulation, mood, and energy levels without overtaxing the body during the drug adaptation period. Persistent, worsening, or debilitating fatigue should prompt medical evaluation to exclude other causes, reassess medication dosing, and ensure safe continuation of GLP-1 therapy under healthcare supervision. Frequently asked questions Why do GLP-1 medications cause fatigue

This reaction accelerates dramatically with temperature, roughly doubling in rate for every 10C increase
Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G (2017) Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter